The Netherlands Cancer Institute has started a study on HIPEC treatment for gastric cancer


Surgeon Johanna van Sandick and gastroenterologist Henk Boot from the Netherlands Cancer Institute have started a study on the efficacy of HIPEC treatment for gastric cancer patients with peritoneal metastases. Former minister Edith Schippers conditionally admitted the treatment to the basic package of the Healthcare Insurance Act for a period of 5 years per October 1st 2017. This involves an amount of € 1,855,000.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.